Tested Applications
| Positive WB detected in | C6 cells, Jurkat cells, NIH/3T3 cells, MCF-7 cells, HeLa cells, K-562 cells |
| Positive IP detected in | K-562 cells |
| Positive IHC detected in | mouse brain tissue, human breast cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | C6 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:1000-1:6000 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
21401-1-AP targets PAK1 in WB, IHC, IF/ICC, IP, CoIP, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse, rat, chicken |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag16102 Product name: Recombinant human PAK1 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 14-65 aa of BC109299 Sequence: APPMRNTSTMIGAGSKDAGTLNHGSKPLPPNPEEKKKKDRFYRSILPGDKTN Predict reactive species |
| Full Name | p21 protein (Cdc42/Rac)-activated kinase 1 |
| Calculated Molecular Weight | 553 aa, 62 kDa |
| Observed Molecular Weight | 61-65 kDa |
| GenBank Accession Number | BC109299 |
| Gene Symbol | PAK1 |
| Gene ID (NCBI) | 5058 |
| RRID | AB_11232232 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q13153 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
The p21-Activated kinase 1 (PAK1), a member of serine-threonine kinases family, was initially identified as an interactor of the Rho GTPases RAC1 and CDC42, which affect a wide range of processes associated with cell motility, survival, metabolism, cell cycle, proliferation, transformation, stress, inflammation, and gene expression(PMID: 32863957). PAK1 is over-expressed in various malignancies such as ovarian, breast, lung, and bladder cancers, and is closely associated with tumor invasion.
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for PAK1 antibody 21401-1-AP | Download protocol |
| IHC protocol for PAK1 antibody 21401-1-AP | Download protocol |
| IP protocol for PAK1 antibody 21401-1-AP | Download protocol |
| WB protocol for PAK1 antibody 21401-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The PAK1 Polyclonal antibody (Cat# 21401-1-AP) has 33 citations. These appear in journals including Nucleic Acids Research, Theranostics, Genes & Diseases, Journal of Controlled Release, Acta Pharmacologica Sinica, ACS Applied Materials & Interfaces, PLoS Biology, Biochemical Pharmacology, Molecular Cancer Research, Molecular Neurobiology, Frontiers in Pharmacology, PLoS Pathogens, Experimental Neurology, Journal of Biological Chemistry, Human Molecular Genetics, and Nature Communications. Research fields span oncology (ovarian, prostate, colorectal, cervical, breast, liver cancers), neuroscience, cardiovascular disease, inflammation, infection, and cell signaling pathways.
| Species | Application | Title |
|---|---|---|
Nucleic Acids Res DOCK7 protects against replication stress by promoting RPA stability on chromatin. | ||
Theranostics Cdc42 Deficiency Leads To Epidermal Barrier Dysfunction by Regulating Intercellular Junctions and Keratinization of Epidermal Cells during Mouse Skin Development. | ||
Genes Dis PAK1 inhibition synergistically enhances the anti-tumor efficacy of PARP inhibitors in ovarian cancers. | ||
J Control Release Dentin tubules as a long-term sustained release carrier to accelerate bone repair by loading FTY720 | ||
Acta Pharmacol Sin Salvianolic acid A prevented cerebrovascular endothelial injury caused by acute ischemic stroke through inhibiting the Src signaling pathway. | ||
ACS Appl Mater Interfaces Novel Thermosensitive Hydrogel Promotes Spinal Cord Repair by Regulating Mitochondrial Function. |



























